PL374961A1 - Process for preparing intermediates - Google Patents

Process for preparing intermediates

Info

Publication number
PL374961A1
PL374961A1 PL03374961A PL37496103A PL374961A1 PL 374961 A1 PL374961 A1 PL 374961A1 PL 03374961 A PL03374961 A PL 03374961A PL 37496103 A PL37496103 A PL 37496103A PL 374961 A1 PL374961 A1 PL 374961A1
Authority
PL
Poland
Prior art keywords
preparing intermediates
intermediates
preparing
lactarn
directed
Prior art date
Application number
PL03374961A
Other languages
English (en)
Polish (pl)
Inventor
Prasad Koteswara Kapa
Xinglong Jiang
Eric M. Loeser
Joel Slade
Mahavir Prashad
George Tien-San Lee
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PL374961A1 publication Critical patent/PL374961A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/04Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D277/06Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Press Drives And Press Lines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
PL03374961A 2002-09-19 2003-09-18 Process for preparing intermediates PL374961A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41192002P 2002-09-19 2002-09-19
US48024203P 2003-06-20 2003-06-20

Publications (1)

Publication Number Publication Date
PL374961A1 true PL374961A1 (en) 2005-11-14

Family

ID=32033579

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03374961A PL374961A1 (en) 2002-09-19 2003-09-18 Process for preparing intermediates

Country Status (20)

Country Link
US (1) US7589216B2 (enExample)
EP (1) EP1542968B1 (enExample)
JP (1) JP2006503053A (enExample)
KR (1) KR20050057429A (enExample)
CN (1) CN100439334C (enExample)
AT (1) ATE417826T1 (enExample)
AU (1) AU2003273404B2 (enExample)
BR (1) BR0314592A (enExample)
CA (1) CA2499426A1 (enExample)
DE (1) DE60325390D1 (enExample)
DK (1) DK1542968T3 (enExample)
EC (1) ECSP055692A (enExample)
ES (1) ES2321504T3 (enExample)
MX (1) MXPA05003089A (enExample)
NO (1) NO20051867L (enExample)
NZ (1) NZ538833A (enExample)
PL (1) PL374961A1 (enExample)
PT (1) PT1542968E (enExample)
RU (1) RU2374227C2 (enExample)
WO (1) WO2004026824A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1512991A (zh) 2001-06-15 2004-07-14 ά����ҩ�﹫˾ 吡咯烷双环化合物
EP1542968B1 (en) 2002-09-19 2008-12-17 Novartis AG Process for preparing intermediates
JP2006519786A (ja) 2003-02-21 2006-08-31 ノバルティス アクチエンゲゼルシャフト N−ホルミルヒドロキシルアミン化合物を得るための中間体作成に関する化学的方法
GT200600196A (es) * 2005-05-23 2007-01-15 Compuestos n-formil de hidroxilamina
CN101434570B (zh) * 2007-11-16 2011-02-02 上海医药工业研究院 吡咯烷衍生物及其制备方法和应用
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU384814A1 (ru) * 1970-12-25 1973-05-29 Всесоюзный научно исследовательский институт тетических , натуральных душистых веществ СПОСОБ ПОЛУЧЕНИЯ р-МЕТИЛЗАМЕЩЕННЫХ со-ОКСИКАРБОНОВЫХ КИСЛОТ
US4115417A (en) 1975-10-16 1978-09-19 Hoffmann-La Roche Inc. Asymmetric hydrogenation catalyzed by rhodium complexes of chiral tertiary phosphines
JPS5377010A (en) * 1976-12-16 1978-07-08 Mitsui Toatsu Chem Inc Preparation of hydroxypivalic acid
JPS6030666B2 (ja) 1980-08-20 1985-07-17 鐘淵化学工業株式会社 光学活性メルカプトカルボン酸の製造法
JPS5953839B2 (ja) * 1980-10-06 1984-12-27 鐘淵化学工業株式会社 (−)−α−ヒドロキシメチル酪酸の製造方法
JPH01149751A (ja) * 1987-12-08 1989-06-12 Agency Of Ind Science & Technol 2−n−ヘキシル−3−ヒドロキシ−n−デカン酸及びそのエステル
AU633260B2 (en) 1988-08-09 1993-01-28 Genencor International, Inc. Chiral hydroxycarboxylic acids from prochiral diols
JPH0592948A (ja) * 1991-02-06 1993-04-16 Yoshitomi Pharmaceut Ind Ltd プロピオン酸アミド誘導体およびその医薬用途
NZ505675A (en) 1998-02-07 2002-11-26 British Biotech Pharm N-alkylamide substituted hydroxamic acid derivatives are used as antibacterial agents
US6977141B2 (en) 1998-02-10 2005-12-20 Vicuron Pharmaceuticals Inc. Direct adsorption scintillation assay for measuring enzyme activity and assaying biochemical processes
AR032920A1 (es) * 2001-03-01 2003-12-03 Smithkline Beecham Corp Compuestos inhibidores de las peptido-deformilasas y medios para tratar infecciones bacterianas utilizando dichos inhibidores
CN1512991A (zh) 2001-06-15 2004-07-14 ά����ҩ�﹫˾ 吡咯烷双环化合物
AR036053A1 (es) 2001-06-15 2004-08-04 Versicor Inc Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas
JP2006052138A (ja) * 2002-08-23 2006-02-23 Dainippon Sumitomo Pharma Co Ltd プロリン誘導体
EP1542968B1 (en) 2002-09-19 2008-12-17 Novartis AG Process for preparing intermediates
JP2006519786A (ja) 2003-02-21 2006-08-31 ノバルティス アクチエンゲゼルシャフト N−ホルミルヒドロキシルアミン化合物を得るための中間体作成に関する化学的方法
TW200427458A (en) 2003-04-02 2004-12-16 Novartis Ag Crystalline N-formyl hydroxylamine compounds
AU2004251876A1 (en) 2003-06-26 2005-01-06 Novartis Ag Process for preparing intermediates useful to prepare certain antibacterial N-formyl hydroxylamines

Also Published As

Publication number Publication date
HK1079513A1 (en) 2006-04-07
NZ538833A (en) 2008-05-30
EP1542968B1 (en) 2008-12-17
AU2003273404B2 (en) 2008-05-22
ATE417826T1 (de) 2009-01-15
ES2321504T3 (es) 2009-06-08
CN1684945A (zh) 2005-10-19
US7589216B2 (en) 2009-09-15
NO20051867D0 (no) 2005-04-18
ECSP055692A (es) 2005-07-06
MXPA05003089A (es) 2005-05-27
RU2005111600A (ru) 2006-10-27
DE60325390D1 (de) 2009-01-29
DK1542968T3 (da) 2009-04-20
JP2006503053A (ja) 2006-01-26
NO20051867L (no) 2005-04-18
BR0314592A (pt) 2005-08-09
US20050261504A1 (en) 2005-11-24
WO2004026824A1 (en) 2004-04-01
EP1542968A1 (en) 2005-06-22
AU2003273404A1 (en) 2004-04-08
CA2499426A1 (en) 2004-04-01
KR20050057429A (ko) 2005-06-16
PT1542968E (pt) 2009-03-25
RU2374227C2 (ru) 2009-11-27
CN100439334C (zh) 2008-12-03

Similar Documents

Publication Publication Date Title
MXPA04012691A (es) Derivados de azabiciclo-octano y nonano con actividad inhibitoria de dpp-iv.
GB0305142D0 (en) Synthesis
IL175770A0 (en) Novel use of peptide compounds for treating central neuropathic pain
TW200639161A (en) Process for the purification of duloxetine hydrochloride
EA200601029A1 (ru) Способ очистки фсг
SG144736A1 (en) Synthesis of temozolomide and analogs
GEP20074215B (en) Novel method for the industrial synthesis of strontium ranelate and the hydrates thereof
MX2007003118A (es) Procedimiento de intermediarios para preparar inhibidores de cisteina proteasa.
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
ITMI20050801A1 (it) Procedimento per la preparazione di telmisartan
SG143062A1 (en) Synthesis of temozolomide and analogs
PL374961A1 (en) Process for preparing intermediates
MXPA05005761A (es) Proceso para preparar (s)-pantoprazola.
GB0327323D0 (en) Novel pharmaceuticals
MXPA05014217A (es) Proceso para preparar intermediarios utiles para preparar ciertas n-formil hidroxilaminas antibacterianas.
UA85701C2 (ru) Способ получения ингибиторов триптазы
MXPA05012004A (es) Nuevos bioisosteros de actinonina.
MX2007007446A (es) Procesos para la produccion de 4-aminoquinazolinas.
MY136288A (en) New process for the synthesis of perindopril and its pharmaceutically acceptable salts
ZA200602149B (en) Process for the synthesis of 6-amino-4-[(3-chloro-4-fluo-rophenyl)amino]-7-ethoxy-quinoline-3-carbonitrile
TW200504066A (en) Crystal of intermediate for carbapenem synthesis
NO20074880L (no) Proteaseinhibitor forloper syntese
MY139289A (en) Process for the synthesis of perindopril and pharmaceutically acceptable salts thereof
PL1912954T3 (pl) Nowe inhibitory proteaz cysteinowych i ich terapeutyczne zastosowania
GB0320738D0 (en) Novel process

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)